Here, it is first reported that human transmembrane protein 65 (TMEM65), a poorly characterized mitochondrial inner‐membrane protein‐encoding gene in human cancer, acts as a novel oncogene in TNBC to promote tumor growth, metastasis, and cisplatin resistance both in vivo and in vitro. The gene discussed is IMMT; the disease is neoplasm.